A Phase 2 interventional study of Permethrin Cream, 5% and Permethrin Cream, 5% in Scabies, sponsored by Children Hospital and Institute of Child Health, Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 6 Years to 15 Years. Per ClinicalTrials.gov, last updated 2025-04-20.
Sponsored by Children Hospital and Institute of Child Health, Lahore · Phase 2, Interventional, and Treatment
Scabies is highly contagious,pruritic infestation of skin.Various treatment modalities have been used but search for ideal scabicide is ongoing.we wnt to coduct this study to compare the outcome of permethrin verses ivermectin in children for treatment of scabies .This randomized clinical trial will be done in children hospital lahore for 12 months.Sample size of 90 cases;30 in each group will be included through non probability consecutive sampling.Then patient will be randomly divided into 3 groups.In group A patient will be given 5% permethrin topical application to whole body single application. In Group B ,patients will be given topical permethrin for twice application 24 hrs appart ,In group C patients will be given Tablet Ivermectin single dose 200microgram/kg.Then patients will be examined after 2 weeks and 4 weeks for no of lesions and pruritis and cure will be labeled.All this information will be recorded on performa .Data will be entered and analysed by using SPSS version 26.Three groups will be compared for cure by using chi-square test.P value less than and equal to 0.05 will be considered as significant.
51 studies on the registry are indexed under Scabies; 10 are open to participants now.
This study's planned enrollment of 90 is below the median of 183 across 41 interventional studies indexed under Scabies.
Browse Scabies studies →Children Hospital and Institute of Child Health, Lahore is the lead sponsor of 10 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group A will be given Permethrin
Drug: Permethrin Cream, 5%
Group B will be given Permethrin 5% cream twice application
Drug: Permethrin Cream, 5%
Group C will be given Tab Ivermectin
Drug: Ivermectin 200 µg/kg
Permethrin 5% cream will be given as a single application
Permethrin Cream will be given as twice application
Drug page: Ivermectin
Group C will be given Tab Ivermectin
Cure of scabies.
Cure will be labeled if greater han 50% reduction in no of lesions and pruritis observed after 4 weeks of treatment.
Time frame: 12 months
Plan to share: No
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ivermectin
Children Hospital and Institute of Child Health, Lahore